Product Information
LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0573 per EA under NDC 00093736798. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Apr 6, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
12.5; 50 mg/1; mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093736798
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUMApproval Type
Generic (ANDA)
FDA Application
ANDA077157FDA Approved
4/6/2010
TE Code
AB
On Market Since
4/6/2010
Pharmacological Classes
Price Statistics
The NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 33.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0573 per EA |
|---|---|
| All-time high | $0.1854 (Apr 15, 2020) |
| All-time low | $0.0573 (Aug 19, 2026) |
| 52-week high | $0.0797 |
| 52-week low | $0.0573 |
| Median price | $0.0840 |
| Average price | $0.0992 |
| Largest weekly change | +46.8% (Dec 18, 2019) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB, manufactured by Teva Pharmaceuticals USA Inc., is $0.0573 per EA (NDC 00093736798), effective Aug 19, 2026.
How has the price of LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB changed over time?
Over the history we have for it, the NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB has declined 33.9%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB?
Since Nov 28, 2013, the NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB has ranged from a low of $0.0573 (Aug 19, 2026) to a high of $0.1854 (Apr 15, 2020), with a median of $0.0840 per EA.
Are there cheaper alternatives to LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB?
LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB (NDC 00093736798) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.